Allspring Global Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Allspring Global Investments’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Buy	20,166 +602	+3%	+$12.5K	﹤0.01%	1490
2026 Q1	$467K	Buy	19,564 +2,002	+11%	+$43.5K	﹤0.01%	1405
2025 Q4	$374K	Buy	17,562 +1,455	+9%	+$25.4K	﹤0.01%	1457
2025 Q3	$253K	Buy	+16,107	New	+$211K	﹤0.01%	1517
2023 Q3	–	Sell	-2,501	Closed	-$52.3K	–	2888
2023 Q2	$52.3K	Sell	2,501 -6,470	-72%	-$135K	﹤0.01%	2281
2023 Q1	$189K	Buy	8,971 +4,435	+98%	+$110K	﹤0.01%	1834
2022 Q4	$115K	Sell	4,536 -123	-3%	-$2.87K	﹤0.01%	2023
2022 Q3	$111K	Buy	4,659 +4,479	+2,488%	+$100K	﹤0.01%	2045
2022 Q2	$3K	Buy	+180	New	+$3K	﹤0.01%	2637

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Allspring Global Investments's SNDX Position: Q2 2026 in Review

Allspring Global Investments increased its Syndax Pharmaceuticals (SNDX) stake by 3.1% in Q2 2026, buying an estimated $12.5K and bringing the position to 20,166 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Allspring Global Investments first reported a position in SNDX in Q2 2022 and has held it in 9 quarters since. The position peaked at $467K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Allspring Global Investments held 20,166 shares of Syndax Pharmaceuticals worth $421K as of Q2 2026.
Allspring Global Investments bought 602 Syndax Pharmaceuticals shares in Q2 2026, an estimated $12.5K.
Syndax Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1490 holding.
Allspring Global Investments first reported a position in Syndax Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
Allspring Global Investments's Syndax Pharmaceuticals position peaked at $467K in Q1 2026.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.